HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

about

Switching to second-line ART in relation to mortality in a large Tanzanian HIV cohort.Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.Upward trends of acquired drug resistances in Ethiopian HIV-1C isolates: A decade longitudinal study.

P2860

Q38848107-A5B0BC0B-B81A-4802-BC15-EFC3A71A8B86 Q39311484-5CC168F5-D6FB-4D39-B7CE-FA2D71647983 Q46662332-60FEB728-9658-4D96-9273-64E1C1423F9B

P2860

HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

Item

http://www.wikidata.org/entity/Q36977381

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

@en

type

Item

label

HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

@en

prefLabel

HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

@en

P1476

HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

@en

P2093

Claudia Hawkins

http://www.w3.org/2001/XMLSchema#string

David Sando

http://www.w3.org/2001/XMLSchema#string

Deborah Carpenter

http://www.w3.org/2001/XMLSchema#string

Eric Aris

http://www.w3.org/2001/XMLSchema#string

Nzovu Ulenga

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high

Monitoring HIV viral load in resource limited settings: still a matter of debate?

Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study

Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda

HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania.

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies.

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda.

P304

1966-1974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/DKW051

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27076106

http://www.w3.org/2001/XMLSchema#string

P921

virology

An Tansáin

P932

4896406

http://www.w3.org/2001/XMLSchema#string

HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

about

P2860

P2860

HIV virological failure and drug resistance in a cohort of Tanzanian HIV-infected adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932